Ostomy Devices Market Size, Share, and COVID-19 Impact Analysis By Product Type (Flat and Convex) By System (One-piece Pouch and Two-piece Pouch), By Surgery Type (Colostomy, Urostomy, and Ileostomy) By End User (Hospitals & ASCs, Specialty Clinics, Homecare, and Others), and Regional Forecast, 2025-2032

An ostomy device or bag is also known as an ostomy pouch, which is held outside of the body and primarily collects urine or stool post-surgery. Ostomy procedures are often performed as a last resort in patients suffering from inflammatory bowel diseases (IBD), ulcerative colitis or Crohn’s disease, and colorectal cancer. There are three types of surgeries performed depending on the patient’s need which includes: colostomy, ileostomy, and urostomy. For patients who are partially or fully paralyzed, mobility often serves as a major impediment as they are bedridden, and undergoing for ostomy procedure is one of the viable options. Moreover, the increasing geriatric population with medical conditions related to bowel or bladder such as fecal incontinence is driving the demand for these products.

• The American Society of Clinical Oncology (ASCO) published in May 2022 that colorectal cancer is the third most common cancer diagnosed in both men and women annually in the U.S. as well as globally. Colorectal cancer is generally diagnosed in people aged 60 and older. Hence, surgery is a common treatment option resulting in permanent dependence on ostomy devices
• As per a study published by the Cureus Journal in June 2022, the incidence of spinal cord injury (SCI) is higher in lower and middle-income countries i.e., 13.69 per 100,000 people compared to higher-income countries i.e., 8.72 per 100,000 people. These patients develop neurogenic bowel and bladder, which adversely affects their quality of life, with constipation and fecal incontinence being two main problems with the prevalence reported to be 40-58% and 2-61%, respectively.

The increasing hospitalization rate for intensive care units (ICUs) with mobility issues along with penetration of domestic market players offering cost-effective products to meet the demand of this patient pool are some of the major factors contributing to the market growth. However, the risk associated with these devices, such as poor stoma siting, skin irritation, high output stoma (HOS), ischemia, retraction, parastomal hernia (PH), and prolapse, may hinder the preference among the patient population leading to slower market growth.

Impact of COVID-19 on the Ostomy Devices Market

The outbreak of COVID-19 impacted the global ostomy devices market negatively as a number of elective non-cancer procedures were suspended or postponed. The COVID-19 pandemic had a major impact on the functioning of healthcare systems around the globe, with many countries allocating all their resources to combat the disease. Many of the cancer patients became reluctant to seek help, due to infection fears, exposing them to considerable cancer progression risks.

• According to a study published in June 2020 by the NCBI, the overall cancellation rate of elective surgery was 82% for benign diseases and 38% for cancer globally, during the first peak of the COVID-19 pandemic, i.e., from 23 January 2020 to 8 April 2020.

Moreover, the number of laparoscopic colorectal surgeries decreased due to the potential risk of aerosol-transmitted exposure to the SARS-CoV-2 virus generated by pneumoperitoneum during the surgery. A study conducted by the Multidisciplinary Italian Study Group for STOmas (MISSTO) recommended that follow-up and elective visits to ostomy care clinics be canceled or postponed as a precautionary action for stoma patients. 

However, as the lockdown restrictions were eased these pending procedures were performed leading the market growth to its pre-pandemic level in terms of patient visits and is anticipated to grow throughout the forecast period 2023-2030.

Key Insights

• Prevalence of Colorectal Cancer, By Key Countries, 2022.
• Number of Ostomy Procedures Performed, By Key Countries, 2022.
• Key Industry Developments - Mergers, Acquisitions, and Partnerships.
• New Product Launches, By Key Players.
• Technological Advancement in Ostomy Devices Market.
• Impact of COVID-19 on the Global Ostomy Devices Market.

Analysis by Surgery Type:

Based on the surgery type, the market is segmented into colostomy, urostomy, and Ileostomy. In the global market colostomy surgery is expected to hold a significant share as it is the most common type of procedure performed among patients suffering from colorectal cancer as well as gastrointestinal diseases. A colostomy is performed to create a stoma opening in the abdomen that is a piece of the colon that is brought outside the abdominal wall through which digested food passes into an external pouch called an ostomy bag.

• As per an article published by NHS 24 in March 2023, it is estimated that around 6,400 permanent colostomies are performed each year in the United Kingdom.

An increase in the number of colostomy procedures across various regions will lead increase in the adoption rate of ostomy devices. Hence, this will drive the segment’s growth in the global market during the forecast period.

Regional Analysis:

To gain extensive insights into the market, Download for Customization

Among regions, North America is expected to dominate the global market, owing to its highest incidence rates of colorectal cancer compared to other regions. Ostomy surgery is one of the most common treatments for colorectal cancer as these are used after the removal of the colon due to colon cancer. The demand for these products will increase as the number of these surgical procedures will increase. Hence, the increase in usage of these products will positively influence the market growth in the forecast period.

• According to the United Ostomy Association of America report published in June 2020, it is estimated that 750,000 to 1 million people have ostomies in the United States and approximately 100,000 new ostomy surgeries are performed each year.

Key Players Covered

The report will include the profiles of key players such as Coloplast Corp, Hollister Incorporated, Convatec Inc., Marlen Manufacturing & Development Company, B. Braun SE, Cymed, Nu-Hope Laboratories, Inc., ALCARE Co., Ltd, Flexicare Medical Ltd., and others.

Segmentation

Key Industry Developments

• April 2021: Medline, U.S. based company entered into a partnership with Ostoform, an Ireland-based start-up to commercialize a range of ostomy barrier rings in the U.S. market.
• March 2021: Covatec Inc., acquired Cure Medical to strengthen and expand their portfolio and offer a more comprehensive range of products and services in continence care.
• August 2020: One Equity Partners (OEP), a private equity firm acquired American Medical Technologies (AMT), a provider of advanced wound care, ostomy, urology and tracheostomy supplies and services.